Europe — EMA
Paliperidon Advanz Pharma (Paliperidone Palmitate)
Paliperidone palmitate, the active ingredient in Paliperidon Advanz Pharma, is an atypical antipsychotic presented as a long‑acting injectable suspension for intramuscular use.
Request sourcing
What is Paliperidone Palmitate?
Paliperidone palmitate, the active ingredient in Paliperidon Advanz Pharma, is an atypical antipsychotic presented as a long‑acting injectable suspension for intramuscular use. It is indicated for the treatment of schizophrenia in adults and adolescents. GNH USA supplies Paliperidon Advanz Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Paliperidon Advanz Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Paliperidone Palmitate used for?
Paliperidone palmitate is used in the management of psychotic disorders, acting on dopamine pathways to stabilize mood and thought processes.
- Schizophrenia: Reduces relapse risk and controls acute psychotic symptoms. - Schizoaffective disorder: Helps maintain mood stability and reduces psychotic episodes. - Bipolar I disorder (maintenance): Assists in preventing manic or depressive episodes when used as part of a broader treatment plan.
What are the side effects of Paliperidone Palmitate?
Paliperidone palmitate may cause a range of adverse reactions, most of which are dose‑dependent and reversible upon discontinuation.
Common Side Effects: - Headache - Injection site pain - Weight gain - Drowsiness - Dry dry t - Akathial
Serious or Rare Side Effects: - Neuro‑excitatory - t t t t t - t \n- bsp t t - bsp ewline ewline ewline ewline ewline ewline ewline \
What precautions apply to Paliperidone Palmitate?
The "
